FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apollo Care SEMAGLUTIDE 20mg Recall

SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Onl…

Apollo Care, LLC · Columbia, MO

Risk level
Class II
Reported by FDA
Aug 19, 2026
Recall ID
D-0757-2026
Check your lot numberHow we source this data

Summary

Apollo Care recalled SEMAGLUTIDE 20mg starting Jul 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0757-2026 on Aug 19, 2026. Reason: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Product description

SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.

Lot numbers, UPCs & expiration codes

Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.

Where it was sold

Nationwide within the U.S

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0757-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 29, 2026
FDA report date
Aug 19, 2026
Quantity
4,250 vials.
Recall type
Voluntary: Firm initiated
Recalling firm
Apollo Care, LLC

Original FDA data

Every field from FDA enforcement report D-0757-2026, exactly as published.

Show all FDA fields
City
Columbia
State
MO
Status
Ongoing
Country
United States
Event ID
99505
Address
3801 Mojave Ct Ste 101
Code information
Lot: AC-017275, Exp. 12/13/2026; AC-017282, AC-017285, Exp. 12/27/2026.
Postal code
65202-4042
Report date
Aug 19, 2026
Product type
Drugs
Recall number
D-0757-2026
Classification
Class II
Recalling firm
Apollo Care, LLC
Product quantity
4,250 vials.
Reason for recall
Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Voluntary / mandated
Voluntary: Firm initiated
Product description
SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.
Distribution pattern
Nationwide within the U.S
Recall initiation date
Jul 29, 2026
Initial firm notification
E-Mail
Center classification date
Aug 7, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0757-2026, published Aug 19, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls